ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2109

Activation of T Follicular Helper Cells through Epigenetic Regulation By STAT1 and STAT4 in Lupus Patients

Shingo Nakayamada1, Xiaoxue Ma1, Satoshi Kubo1, Yusuke Miyazaki1, Kaoru Yamagata1, Kazuhisa Nakano1 and Yoshiya Tanaka2, 1First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2University of Occupational and Environmental Health, Kitakyushu, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cytokines, Epigenetics, signal transduction and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: During the T cell differentiation, signal transducer and activators of transcription (STAT) family transcription factors play pivotal roles in specifying T cell lineages. T follicular helper (Tfh) cells serve important roles in the development and progression of systemic lupus erythematosus (SLE). To assess the characteristics and mechanisms of differentiation of Tfh cells, we studied the underlying epigenetic modifications by cytokine-induced STAT activation and the phenotype of circulating T helper cells in SLE patients.

Methods: Peripheral blood mononuclear cells from patients with SLE and healthy controls (HC) were analyzed by flow cytometry. The phenotype of circulating T cells was defined based on flow cytometric analysis for human immune system termed “the Human Immunology Project” proposed by NIH/FOCIS. Naive CD4+ T cells and memory CD4+ T cells were isolated and cultured with T cell receptor (TCR) and various cytokines in vitro. Expression of characteristic markers of Tfh cells and phosphorylation of STATs were analyzed by flow cytometry and qPCR. Histone modifications were evaluated by chromatin immunoprecipitation (ChIP)-PCR. Peripheral blood mononuclear cells from SLE patients and healthy controls were analyzed by flow cytometry and productions of cytokines in serum were tested by cytometric bead array.

Results: Among the immunoregulatory cytokines, IL-12 induced the differentiation of CD4+CXCR5+CXCR3+Bcl-6+T-bet+IL-21+IFN-γ+ T cells, which share features of both Tfh and Th1 cells. The loci of Bcl-6 and T-bet at STAT binding sites were marked by bivalent histone modifications. After IL-12-stimulation, both STAT1 and STAT4 were phosphorylated simultaneously and directly bound on BCL6 (encoding Bcl-6) and TBX21 (encoding T-bet) gene loci accompanied by suppression of repressive histone mark trimethylated histone 3 lysine 27. Compared with HCs, the proportion of CD4+CXCR5+CXCR3+CCR6–CD69+ activated Tfh-Th1-like cells were significantly increased in patients with SLE (mean 0.7 vs 0.4, p=0.02). Levels of serum IL-12 and expression of IL-12 receptors in memory T cells were significantly increased in patients with SLE compared to HCs (p<0.01). Furthermore, the level of pSTAT1, pSTAT4 and T-bet were higher in activated Tfh-Th1-like cells than non-Tfh-Th1 cells (p<0.05).

Conclusion: The findings suggest that IL-12-mediated co-activation of STAT1 and STAT4 alters histone modification, resulting in development of Tfh-Th1-like cells that are characteristically expanded in patients with SLE. This could be one of underlying mechanisms responsible for the pathogenesis of Tfh cells in SLE. Thus, modulation of STAT-mediated gene regulation in Tfh cells potentially offer the opportunities for cell-specific treatment of SLE.


Disclosure: S. Nakayamada, Bristol-Myers, UCB, Astellas, Abbvie, Eisai, Pfizer, Takeda, 8,Mitsubishi-Tanabe, Novartis and MSD, 2; X. Ma, None; S. Kubo, Bristol-Myers, Pfizer, and Takeda, 8; Y. Miyazaki, None; K. Yamagata, None; K. Nakano, UCB, Astellas, Mitsubishi-Tanabe, 8,Mitsubishi-Tanabe and Eisai, 2; Y. Tanaka, Daiichi-Sankyo, Astellas, Pfizer, Mitsubishi-Tanabe, Bristol-Myers, Chugai, YL Biologics, Eli Lilly, Sanofi, Janssen, UCB, 8,Mitsubishi-Tanabe, Takeda, Bristol-Myers, Chugai, Astellas, Abbvie, MSD, Daiichi-Sankyo, Pfizer, Kyowa- Kirin, Eisai, Ono, 2.

To cite this abstract in AMA style:

Nakayamada S, Ma X, Kubo S, Miyazaki Y, Yamagata K, Nakano K, Tanaka Y. Activation of T Follicular Helper Cells through Epigenetic Regulation By STAT1 and STAT4 in Lupus Patients [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/activation-of-t-follicular-helper-cells-through-epigenetic-regulation-by-stat1-and-stat4-in-lupus-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activation-of-t-follicular-helper-cells-through-epigenetic-regulation-by-stat1-and-stat4-in-lupus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology